Article Text
PostScript
Letter
Efficacy of granulocyte/monocyte apheresis for moderate to severe Crohn's disease
Statistics from Altmetric.com
We read the article by Sands et al1 with interest. The efficacy of granulocyte/monocyte apheresis (GMA) in inflammatory bowel disease (IBD) is controversial, with previous studies mainly conducted in Japan, involving small numbers of patients, often without sham controls.2–4 The authors should, therefore, be congratulated for performing a large, randomised, double-blind, sham-controlled study of GMA in moderate to severely active Crohn's disease in a Western population.
The …
Footnotes
Contributors JEA and ACF drafted the manuscript.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.